$NVLX By comparison, two independent Phase II clinical trials revealed that Nuvilex's pancreatic cancer treatment, namely the combination of tiny capsules containing live drug-activating cells together with the single cancer drug ifosfamide (used for many years to treat a variety of cancers), helped patients to a far better outcome than that previously reported with standard single-drug gemcitabine and even that reported for the just approved ABRAXANE-gemcitabine combination.
News 
Market Data 
Discover 
